Precision BioSciences, Inc.
DTIL
$4.91
$0.122.40%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -83.60M | -78.26M | -21.99M | 7.17M | 8.62M |
| Total Depreciation and Amortization | 2.83M | 3.17M | 3.86M | 4.58M | 5.38M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 8.62M | 4.28M | -5.42M | -16.19M | -10.24M |
| Change in Net Operating Assets | -1.13M | 6.88M | -34.97M | -54.00M | -51.95M |
| Cash from Operations | -73.28M | -63.92M | -58.52M | -58.45M | -48.19M |
| Capital Expenditure | -163.00K | -202.00K | -228.00K | -250.00K | -127.00K |
| Sale of Property, Plant, and Equipment | 22.00K | 5.00K | 0.00 | 60.00K | 97.00K |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -265.00K | -290.00K | -275.00K | -25.00K | 7.95M |
| Cash from Investing | -406.00K | -487.00K | -503.00K | -215.00K | -76.00K |
| Total Debt Issued | -20.00K | 22.47M | 22.47M | 22.47M | 22.49M |
| Total Debt Repaid | 0.00 | -22.51M | -22.51M | -22.51M | -22.51M |
| Issuance of Common Stock | 23.59M | 25.68M | 21.08M | 50.49M | 47.38M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 23.57M | 25.64M | 21.04M | 50.45M | 47.36M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -50.12M | -38.77M | -37.98M | -8.21M | -903.00K |